VMBIP Newsletter – June 13, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-23-08: 74.1 percent
Week Ending 5-30-08: 73.3 percent
Week Ending 6-6-08: 98.2 percent
Weighted Average Last 3 Weeks:  82.3 percent 
Explanation:  The residual effect of the duplicate orders continue to plague distribution this week.

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-23-08: 89.7 percent
Week Ending 5-30-08: 99.2 percent
Week Ending 6-6-08: 99.8 percent
Weighted Average Last 3 Weeks: 96 percent 
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 5-23-08: 99.98 percent
Week Ending 5-30-08: 99.88 percent
Week Ending 6-6-08: 99.98 percent
Weighted Average Last 3 Weeks:  99.91 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 5-23-08: 99.11 percent
Week Ending 5-30-08: 99.77 percent
Week Ending 6-6-08: 99.98 percent
Weighted Average Last 3 Weeks:  99.62 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 5-23-08: 99.90 percent
Week Ending 5-30-08: 99.90 percent
Week Ending 6-6-08: 99.98 percent
Weighted Average Last 3 Weeks:  99.93 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 5-23-08: 100 percent
Week Ending 5-30-08:  100 percent
Week Ending 6-6-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent 
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending 5-23-08: 100 percent
Week Ending 5-30-08: 100 percent
Week Ending 6-6-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent 
Explanation:  None.

A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.    percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.   percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable or customer not available, or carrier damage
C2.    percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address and delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.    percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.    percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) and 48 (other) hrs of delivery by manufacturer
F.    percent of grantee replenishment orders McKesson faxes and e-mails receipt of to grantees within 48 hrs of delivery by manufacturer

Vaccines on allocation DTaP-Hib, HepB-Hib, Hib (TriHibit) PedvaxHib and ActHib and Flu; Manufacture shortage (Merck Hep A)
Vaccines placed in backorder during the most recent week:  Hep A (30 doses) and Hep A-Adult (100 does), both Merck products – vaccine is on shortage and has been since 2007.  Possible incorrect vaccine selection in VACMAN:  Hep AB (800 doses) – inventory was received day after vaccine was placed on backorder, MMR (650 doses).  Outbreak caused increase in demand coupled with delayed delivery of inventory from manufacturer – orders pending delivery; TD (4960 doses) delayed delivery from manufacturer – inventory received on June 3 and 4, backorders are now processing.

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-23-08: 75.4 percent
Week Ending 5-30-08: 94.2 percent
Week Ending 6-6-08: 98 percent
Weighted Average Last 3 Weeks: 88.2 percent  
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-23-08: 86.2 percent
Week Ending 5-30-08: 98.8 percent
Week Ending 6-6-08: 99.8 percent
Weighted Average Last 3 Weeks: 94.2 percent
 Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-23-08:  70 percent
Week Ending 5-30-08: 42.8 percent
Week Ending 6-6-08: 98.5 percent
Weighted Average Last 3 Weeks: 69.8 percent 
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-23-08: 100 percent
Week Ending 5-30-08:  99.9 percent
Week Ending 6-6-08: 99.8 percent
Weighted Average Last 3 Weeks: 99.8 percent
Explanation:  none
 
A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder – an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order
B.   percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder

VMBIP Updates

•	Attention grantees serviced by the Sacramento Distribution Center: CDC has authorized McKesson to ship approximately 200 vaccine orders this Saturday for delivery to providers Monday, June 16. These orders will be shipped only if the provider has Monday open hours in VACMAN.

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-06-13-08.rtf